Holen Sie sich die Stockscreener-App
7.51
3.59%
-0.28
Schlusskurs vom Vortag:
$7.79
Offen:
$7.78
24-Stunden-Volumen:
1.47M
Relative Volume:
1.38
Marktkapitalisierung:
$657.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-5.6894
EPS:
-1.32
Netto-Cashflow:
$-79.09M
1W Leistung:
+0.00%
1M Leistung:
+7.90%
6M Leistung:
+172.10%
1J Leistung:
-9.95%
1-Tages-Spanne:
$7.50
$7.90
1-Wochen-Bereich:
$7.3501
$7.995
52-Wochen-Spanne:
$1.865
$8.46
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Firmenname
Terns Pharmaceuticals Inc
Sektor
Branche
Telefon
650-525-5535 EXT.101
Adresse
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Vergleichen Sie TERN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
7.51 | 681.71M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Eingeleitet | Barclays | Overweight |
| 2025-09-04 | Fortgesetzt | H.C. Wainwright | Neutral |
| 2025-02-28 | Eingeleitet | William Blair | Mkt Perform |
| 2024-10-31 | Eingeleitet | Oppenheimer | Outperform |
| 2023-06-22 | Eingeleitet | Mizuho | Buy |
| 2023-06-07 | Eingeleitet | Jefferies | Buy |
| 2023-05-31 | Eingeleitet | ROTH MKM | Buy |
| 2023-05-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-14 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-02-07 | Eingeleitet | UBS | Buy |
| 2022-09-12 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-14 | Fortgesetzt | Goldman | Buy |
| 2021-03-02 | Eingeleitet | Cowen | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Buy |
| 2021-03-02 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Terns Pharmaceuticals Inc Aktie (TERN) Neueste Nachrichten
We're Hopeful That Terns Pharmaceuticals (NASDAQ:TERN) Will Use Its Cash Wisely - Yahoo Finance
Terns Pharmaceuticals: Valued As If It Can't Win - Seeking Alpha
Predicting Terns Pharmaceuticals Inc. trend using moving averagesJuly 2025 Catalysts & Community Consensus Stock Picks - newser.com
Detecting price anomalies in Terns Pharmaceuticals Inc. with AI2025 Investor Takeaways & Daily Stock Trend Watchlist - newser.com
Volume spikes in Terns Pharmaceuticals Inc. stock – what they meanQuarterly Portfolio Review & Free Low Drawdown Momentum Trade Ideas - newser.com
How Terns Pharmaceuticals Inc. stock valuations compare to rivalsMarket Growth Report & Pattern Based Trade Signal System - newser.com
Is Terns Pharmaceuticals Inc a good long term investmentRisk Adjusted Returns & High Yield Stock Picks - earlytimes.in
What analysts say about Terns Pharmaceuticals Inc stockEarnings Growth Projections & Affordable Market Growth - earlytimes.in
Does Terns Pharmaceuticals Inc. qualify in momentum factor screeningJuly 2025 Action & Risk Controlled Stock Alerts - newser.com
Will Terns Pharmaceuticals Inc. stock see insider buyingDollar Strength & Daily Entry Point Alerts - The British Mountaineering Council
Exchange Traded Concepts LLC Grows Stock Position in Terns Pharmaceuticals, Inc. $TERN - Defense World
Full technical analysis of Terns Pharmaceuticals Inc. stockTrade Entry Summary & Long-Term Safe Investment Ideas - newser.com
Goldman Sachs Group Inc. Has $1.15 Million Stock Position in Terns Pharmaceuticals, Inc. $TERN - Defense World
Technical analysis overview for Terns Pharmaceuticals Inc. stockWeekly Trade Summary & Verified Short-Term Trading Plans - newser.com
Can Terns Pharmaceuticals Inc. rally from current levels2025 Momentum Check & Daily Stock Momentum Reports - newser.com
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
2 Under-the-Radar Stocks That Could Soar - Mitrade
Fed Meeting: Is Terns Pharmaceuticals Inc a top pick in the sectorJuly 2025 Opening Moves & Fast Gain Swing Alerts - خودرو بانک
Aug Wrap: Is Terns Pharmaceuticals Inc stock a good dividend stockWeekly Stock Analysis & Fast Exit Strategy with Risk Control - خودرو بانک
Analyzing Terns Pharmaceuticals Inc. with multi timeframe charts2025 Key Lessons & Fast Exit and Entry Trade Guides - newser.com
How high can Terns Pharmaceuticals Inc. stock goQuarterly Portfolio Report & Consistent Return Strategy Ideas - newser.com
Published on: 2025-09-19 23:29:17 - خودرو بانک
Profit Review: Will Terns Pharmaceuticals Inc benefit from current market trendsJuly 2025 Fed Impact & Precise Entry and Exit Recommendations - خودرو بانک
Trend analysis for Terns Pharmaceuticals Inc. this weekBreakout Watch & Real-Time Volume Analysis Alerts - newser.com
Identifying reversal signals in Terns Pharmaceuticals Inc.Quarterly Profit Report & Advanced Swing Trade Entry Alerts - newser.com
Statistical indicators supporting Terns Pharmaceuticals Inc.’s strength2025 Price Targets & Smart Swing Trading Techniques - newser.com
Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans - 富途牛牛
Buy Signal: How cyclical is First Bancorp’s revenue streamTake Profit & AI Enhanced Execution Alerts - khodrobank.com
Short Covering: Is Aviat Networks Inc. subject to activist investor interestMarket Growth Review & Stock Timing and Entry Methods - khodrobank.com
Terns Pharmaceuticals (NASDAQ:TERN) Research Coverage Started at Barclays - Defense World
What’s the recovery path for long term holders of Terns Pharmaceuticals Inc.2025 Top Gainers & High Conviction Buy Zone Alerts - newser.com
AI Stocks: Is Terns Pharmaceuticals Inc stock risky to hold nowJuly 2025 PreEarnings & Weekly Chart Analysis and Trade Guides - خودرو بانک
Published on: 2025-09-18 21:20:23 - newser.com
Can you recover from losses in Terns Pharmaceuticals Inc.CEO Change & AI Based Buy and Sell Signals - newser.com
Using portfolio simulators with Terns Pharmaceuticals Inc. includedQuarterly Profit Summary & Smart Allocation Stock Reports - newser.com
Terns Pharmaceuticals (NASDAQ:TERN) Coverage Initiated by Analysts at Barclays - Defense World
Terns Pharmaceuticals’ SWOT analysis: promising CML and obesity drugs drive stock outlook - Investing.com UK
COMMODORE CAPITAL LP Acquires Significant Stake in Terns Pharmaceuticals Inc - GuruFocus
Dip Buying: Is Terns Pharmaceuticals Inc. part of any ETFJuly 2025 Opening Moves & Stepwise Trade Signal Guides - خودرو بانک
Terns Pharmaceuticals (NASDAQ:TERN) Shares Down 3.5%Here's What Happened - MarketBeat
S P Trends: Is Terns Pharmaceuticals Inc a top pick in the sectorJuly 2025 Selloffs & Reliable Intraday Trade Alerts - خودرو بانک
Barclays Initiates Coverage on Terns Pharma (TERN) with Overweig - GuruFocus
Barclays initiates Terns Pharmaceuticals stock with Overweight rating By Investing.com - Investing.com Canada
Barclays initiates Terns Pharmaceuticals stock with Overweight rating - Investing.com
COMMODORE CAPITAL LP Acquires Significant Stake in Terns Pharmac - GuruFocus
What is Terns Pharmaceuticals Incs 5 year growth outlook2025 Volatility Report & Accurate Entry and Exit Point Alerts - خودرو بانک
Order flow analysis tools used on Terns Pharmaceuticals Inc.Quarterly Profit Review & Long-Term Capital Growth Strategies - newser.com
Jacobs Levy Equity Management Inc. Acquires New Shares in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
What’s next for Terns Pharmaceuticals Inc. stockMarket Performance Recap & Free Accurate Trade Setup Notifications - khodrobank.com
Market Wrap: Is Willow Lane Acquisition Corp. impacted by rising ratesJuly 2025 Technicals & Proven Capital Preservation Methods - خودرو بانک
Levels Update: Does SkyWater Technology Inc. outperform in volatile markets2025 Trading Volume Trends & Growth Oriented Trading Recommendations - خودرو بانک
Finanzdaten der Terns Pharmaceuticals Inc-Aktie (TERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):